BioTuesdays

Category - News

Tonix Pharmaceuticals Logo
Markets

Roth cuts Tonix Pharma to neutral; PT $1

Roth Capital Partners downgraded Tonix Pharmaceuticals (NASDAQ:TNXP) to “neutral” from “buy” with a price target of $1 after the company posted disappointing results from its interim Phase 3 analysis of Tonmya for the...

July 27, 2018
restorbio Logo
Markets

Leerink ups resTORbio PT to $45 from $35

Leerink raised its price target for resTORbio (NASDAQ:TORC) to $45 from $35 after the company announced positive top-line results from its Phase 2b clinical trial of RTB101. The stock finished at $13.47 on July 25. The...

July 26, 2018
Synexus Logo
Developments

Synexus in U.S. registry study on brain ageing

Synexus, a leading global network of research sites, is collaborating with the University of Exeter in the UK to launch one of the largest, registry-based research initiatives in the U.S. to help understand how healthy...

July 25, 2018
Neuronetics Logo
Markets

Canaccord starts Neuronetics at buy; PT $33

Canaccord Genuity initiated coverage of Neuronetics (NASDAQ:STIM) with a “buy” rating and $33 price target. The stock closed at $26.02 on July 23. “Possessing a clinically validated, proprietary, non-invasive technology...

July 24, 2018
Profound Medical Logo
Markets

Canaccord starts Profound Medical at buy; PT $2

Canaccord Genuity initiated coverage of Profound Medical (TSX:PRN; OTCQX:PRFMF) with a “buy” rating and price target of $2. The stock closed at 94 cents on July 23. “Profound Medical has the makings of an exciting med...

July 24, 2018